Quick Answer
NextCure, Inc. reported Total Assets of $50.18 million for the year ending 2025.
- NextCure, Inc. showed a decrease of -37.9% in Total Assets from 2024 to 2025.
- This data is from NextCure, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $145.43 million | Q2 2019: $213.05 million | Q3 2019: $205.12 million | Q1 2020: $343.47 million | Q2 2020: $333.49 million | Q3 2020: $316.08 million | Q1 2021: $290.96 million | Q2 2021: $275.36 million | Q3 2021: $257.83 million | Q1 2022: $222.75 million | Q2 2022: $206.37 million | Q3 2022: $189.91 million | Q1 2023: $167.79 million | Q2 2023: $153.38 million | Q3 2023: $139.94 million | Q1 2024: $115.16 million | Q2 2024: $102.59 million | Q3 2024: $90.35 million | Q1 2025: $67.14 million | Q2 2025: $47.69 million | Q3 2025: $39.61 million.
- Over the full 8 years of available data (2018 to 2025), NextCure, Inc.'s Total Assets has declined by 66.0%.
- Historical annual values: Fiscal year 2025: $50.18 million | Fiscal year 2024: $80.86 million | Fiscal year 2023: $128.04 million | Fiscal year 2022: $184.16 million | Fiscal year 2021: $242.39 million | Fiscal year 2020: $306.64 million | Fiscal year 2019: $356.17 million | Fiscal year 2018: $147.63 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: